InVivoMAb Anti-Human IL6 Antibody (TBS10347)
$489.00 – $2,399.00
Target: Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor.
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10347-0.5MG | Yes | 0.5 MG | $489.00 | |||
| TBS10347-1MG | Yes | 1 MG | $719.00 | |||
| TBS10347-5MG | Yes | 5 MG | $2,399.00 |
- Description
- Terms
- Additional information
- Documents
- Reviews (0)
Description
InVivoMAb Anti-Human IL-6 antibody is a monoclonal antibody that specifically targets human interleukin-6 (IL-6), a key cytokine involved in inflammation and immune regulation. By blocking IL-6 signaling, this antibody is widely used in research to investigate inflammatory pathways and to explore the role of IL-6 in autoimmune and chronic inflammatory diseases.
Synonyms: Anti-Human IL-6 monoclonal antibody, Anti-IL-6 antibody, Human IL-6 neutralizing antibody, IL-6 blocking antibody, IL-6–specific monoclonal antibody.
Product Details
| Applications: | ELISA, FCM, Neutralization |
| Species reactivity: | Human |
| Host: | Human |
| Isotype: | IgG1, kappa |
| Target: | Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor. |
| Uniprot: | P05231 |
| Concentration: | 3 mg/ml |
| Purity: | >95% |
| Formulation: | Liquid |
| Storage buffer: | 0.01M PBS, pH 7.4. |
| Purification: | Protein A/G purified from cell culture supernatant. |
| Clonality: | Monoclonal |
| Storage: | Store -20°C up to 12 months, and -80°C for long term. Avoid repeated freeze-thaw cycles. |
Data Image
Fig. 1. SDS-PAGE for InVivoMAb Anti-Human IL6.
MW: Molecular Weight (kDa) Marker.
R: Reducing conditions.
NR: Non-Reducing conditions.
Fig. 2. Western blot analysis was performed using anti-IL6 monoclonal antibody at 1μg/ml on various samples.
Lane 1: recombinant human IL6, 50ng.
Lane 2: recombinant human IL6, 30ng.
Lane 3: recombinant human IL6, 20ng.
Lane 4: recombinant human IL6, 10ng.
Fig. 3. Flow-cytometry using anti-human IL6 antibody. LPS treated THP-1 cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IL6 antibody monoclonal antibody (Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody and cells analyzed on a NovoCyte Flow Cytometer.
Fig. 4. Flow-cytometry using anti-human IL6 antibody. IL6 Transfected CHO cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IL6 antibody monoclonal antibody (Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody and cells analyzed on a NovoCyte Flow Cytometer.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 5 MG, 0.5 MG |
|---|
Datasheet:
TBS10347 InVivoMAb Anti-Human IL6 antibody_Datasheet
MSDS:
TBS10347_InVivoMAb Anti-Human IL6 Antibody_MSDS
Research use only.
Be the first to review “InVivoMAb Anti-Human IL6 Antibody (TBS10347)”
You must be logged in to post a review.
Reviews
There are no reviews yet.